Manufacturer of Active Pharmaceutical Ingredients : Cisplatin IP/BP/USP, Cyclophosphamide (Sterile) IP/BP/USP, Cyclophosphamide (Non Sterile) IP/BP/USP, Carboplatin BP/USP, Glycopyrrolate USP, Doxapram Hydrochloride BP/USP, Hydroxyurea BP/USP, Letrozole USP, Leflunomide BP/EP, Chiral Compounds : 1,2:5, 6-Di Isopropylidene-Alpha-D-Glucofuranose [582-52-5], 1,2-O-Isopropylidine-Alpha-D-Glucofuranose [18549-40-1], 1,2,3,4,6-Penta-O-Acetyl-Alpha-D-Glucopyranose [604-68-2], (-)-O,O'-Dibenzoyl-L-Tartaric Acid (Monohydrate) [62708-56-9), (+)-O,O'-Dibenzoyl-D-Tartaric Acid (Monohydrate) [80822-15-7], (R)-Phenylglycinol [56613-80-0], (S)-Phenylglycinol [20989-17-7], (R)-Phenylalanilol [5267-64-1], (S)-Phenylalanilol [3182-95-4], (S)-Valinol [2026-48-4], (R)-Valinol [4267-09-9], (S)-4-Benzyl-2-Oxazolidinone [90719-32-7], (R)-4-Benzyl-2-Oxazolidinone [102029-44-7], (S)-4-Phenyl-2-Oxazolidinone [99395-88-7], (R)-4-Phenyl-2-Oxazolidinone [90319-52-1], (S)-4-Isopropyl-2-Oxazolidinone [17016-83-0], (R)-4-Isopropyl-2-Oxazolidinone [95530-58-8}, Beta-D-Glucose Pentacetate [604-69-3], Di-O-O'-P-Toluyl-D-Tartaric Acid (Anhydrous) [32634-68-7], Di-O-O'-P-Toluyl-L-Tartaric Acid (Anhydrous) [32634-66-5], Newly Introduced : Anastrazole, Gefitinib, Imatinib Mesylate, Zolendronic Acid